SMC OKs four new therapies for NHS use in Scotland
Cost regulators in Scotland have approved NHS funding for four new medicines, expanding treatment options for lung cancer, iron excess, hepatitis C and chronic pain, but Janssen’s Darzalex was rejected for multiple myeloma.
Read More
